InsidersTradesSigma
Track the 동성제약 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 동성제약 has recorded 6 reports. Market capitalisation: €171.5bn. The latest transaction was reported on 15 April 2026 (Purchase). Among the most active insiders: 유암코제약산업제1호기업재무안정사모투자. The full history is openly available.
6
Insider Decl.
n/a
Thresholds
€96m
5 ops.
Buy Volume
€4m
1 ops.
Sell Volume
12Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,484 of 29,064 companies
24.4
score / 100
Value15
Quality34
FCF yld-9.0%
Earn yld-16%
EV/EBITDA·
ROE2.9%
Gross mgn43%
Net mgn-30%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 15 April 2026
Declarations6 total
31,500,000 shares@ ₩1,000.000.017% mcap100.0% of flowShareKRXDART:20260415000145
8,500,000 shares@ ₩1,000.000.0047% mcap100.0% of flowShareKRXDART:20260415000150
50,000,000 sharesKRXDART:20260415000133
70,000,000 sharesKRXDART:20260406003017
6 of 6 declarations
关于 동성제약
Dong Sung Pharmaceutical 是一家专注于健康和制药领域的韩国公司。它在XKRX市场上市。